title: A computer modeling postulated mechanism for angiotensin II receptor activation.
abstract: The angiotensin II receptor of the AT1-type has been modeled starting from the experimentally determined three-dimensional structure of bacteriorhodopsin as the template. Intermediate 3D structures of rhodopsin and beta 2-adrenergic receptors were built because no direct sequence alignment is possible between the AT1 receptor and bacteriorhodopsin. Docking calculations were carried out on the complex of the modeled receptor with AII, and the results were used to analyze the binding possibilities of DuP753-type antagonistic non-peptide ligands. We confirm that the positively charged Lys199 on helix 5 is crucial for ligand binding, as in our model; the charged side chain of this amino acid interacts strongly with the C-terminal carboxyl group of peptide agonists or with the acidic group at the 2'-position of the biphenyl moiety of DuP753-type antagonists. Several other receptor residues which are implicated in the binding of ligands and the activation of receptor by agonists are identified, and their functional role is discussed. Therefore, a plausible mechanism of receptor activation is proposed. The three-dimensional docking model integrates most of the available experimental observations and helps to plan pertinent site-directed mutagenesis experiments which in turn may validate or modify the present model and the proposed mechanism of receptor activation.
authors.affiliation: Laboratoire de Chimie Théorique, Université de Nancy I, Faculté des Sciences, Vandoeuvre-lès-Nancy, France.
authors.forename: M P
authors.initials: MP
authors.lastname: Joseph
authors.forename: B
authors.initials: B
authors.lastname: Maigret
authors.forename: J C
authors.initials: JC
authors.lastname: Bonnafous
authors.forename: J
authors.initials: J
authors.lastname: Marie
authors.forename: H A
authors.initials: HA
authors.lastname: Scheraga
mesh_terms: D000595:Amino Acid Sequence; D000804:Angiotensin II / Q000378:metabolism; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D001665:Binding Sites; D001713:Biphenyl Compounds / Q000378:metabolism / Q000494:pharmacology; D003198:Computer Simulation; D006801:Humans; D007093:Imidazoles / Q000378:metabolism / Q000494:pharmacology; D019808:Losartan; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D011487:Protein Conformation; D051381:Rats; D011945:Receptors, Angiotensin / Q000737:chemistry* / Q000378:metabolism*; D017386:Sequence Homology, Amino Acid; D013777:Tetrazoles / Q000378:metabolism / Q000494:pharmacology
chemical_list: D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D007093:Imidazoles; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D000804:Angiotensin II; D019808:Losartan